计算溶液所需的质量、体积或浓度。
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
MK-2894 sodium salt is a potent, selective, orally active and high affinity ( K i =0.56 nM) full antagonist against E prostanoid receptor 4 (EP4 receptor) ( IC 50 =2.5 nM). MK-2894 sodium salt possesses potent anti-inflammatory activity in animal models of pain/inflammation and can be used for the research of arthritis.
In Vivo
MK-2894 sodium salt (oral administration, 20 mg/kg; intravenous injection, 5 mg/kg) exhibits a favorable pharmacokinetic profile in mice, the moderate bioavailability F=21%, and slow to moderate clearance rate (CL=23 mL/min/kg), the volume of distribution (V dss =7.6 L/kg), good elimination half-lives (T 1/2 =15 h) and the maximum concentration reached (C max =1.4 μM) in mice . MK-2894 sodium salt (oral administration, 20 mg/kg; intravenous injection, 5 mg/kg) exhibits a favorable pharmacokinetic profile in SD-rats, the moderate bioavailability F=29%, and slow to moderate clearance rate (CL=9.2 mL/min/kg), the volume of distribution (V dss =2.6 L/kg), good elimination half-lives (T 1/2 =4.5 h) and the maximum concentration reached (C max =4.5 μM) in mice . MK-2894 sodium salt (oral administration, 5 mg/kg; intravenous injection, 1 mg/kg) exhibits a favorable pharmacokinetic profile in dogs, the moderate bioavailability F=32%, and slow to moderate clearance rate (CL =23 mL/min/kg), the volume of distribution (V dss =0.91 L/kg), good elimination half-lives (T 1/2 =8.8 h) and the maximum concentration reached (C max =3.3 μM) in mice . MK-2894 sodium salt (oral administration; 0.1 mg/kg-10 mg/kg; single dose) inhibits the acute carrageenan-induced mechanical hyperalgesia model in SD rats in a dose-dependent manner, it displays a inhibition of pain response when measured at 3 h post subplantar injection of carrageenan . MK-2894 sodium salt (oral administration; 0.1 mg/kg-10 mg/kg;5 days) exhibits potent activity in inhibiting chronic paw swelling, in both the primary paw and the secondary paw, in a dose-dependent manner, the ED 50 value is 0.02 mg/kg/day. The complete inhibition of the secondary paw swelling is at an ED 100 of 0.1 mg/kg/day with a plasma concentration of 4 nM at 24 h after the final dose in an adjuvant-induced arthritis rat model . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 三氟甲基苯 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 三氟甲基苯 |
| 其他上位类(Alternative Parents) | 苯甲酸 噻吩甲酰胺 苯甲酰衍生物 杂芳族化合物 仲羧酸酰胺 羧酸盐 羧酸 有机金属卤化物 有机氧化物 碳氢化合物衍生物 有机钠盐 有机两性离子 有机氟化物 有机氮化合物 有机氧化合物 烷基氟化物 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 氟化烷基 - 烷基溴化物 - 芳香族杂单环化合物 - 苯甲酸 - 苯甲酸或衍生物 - 苯甲酰 - 羧酰胺基 - 羧酰胺基 - 羧酸衍生物 - 羧酸盐 - 杂芳香族化合物 - 烃衍生物 - 有机碱金属盐 - 有机金属卤化物 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机盐 - 有机钠盐 - 有机双性离子 - 有机氟化物 - 有机卤化物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 醛基 - 噻吩 - 噻吩甲酰胺 - 噻吩羧酸或其衍生物 - 三氟甲基苯 |
| 描述(Description) | 该化合物属于有机化合物中的三氟甲基苯类。这类含氟有机化合物在苯环上取代有一个或多个三氟甲基基团。 |
| 外部描述符(External Descriptors) | 暂无 |